Home/Filings/4/A/0001192482-18-000107
4/A//SEC Filing

GAUSLING MICHAEL J 4/A

Accession 0001192482-18-000107

CIK 0001651561other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 3:03 PM ET

Size

13.8 KB

Accession

0001192482-18-000107

Insider Transaction Report

Form 4/AAmended
Period: 2017-12-08
Transactions
  • Sale

    Common Stock

    2017-12-11$25.85/sh160,375$4,145,6941,229,898 total
  • Sale

    Common Stock

    2017-12-08$25.85/sh523,805$13,540,3591,390,723 total
Transactions
  • Sale

    Common Stock

    2017-12-08$25.85/sh523,805$13,540,3591,390,723 total
  • Sale

    Common Stock

    2017-12-11$25.85/sh160,375$4,145,6941,229,898 total
BRESSNER GLEN R
Director10% Owner
Transactions
  • Sale

    Common Stock

    2017-12-08$25.85/sh523,805$13,540,3591,390,723 total
  • Sale

    Common Stock

    2017-12-11$25.85/sh160,375$4,145,6941,229,898 total
Arnson Eric R
10% Owner
Transactions
  • Sale

    Common Stock

    2017-12-11$25.85/sh160,375$4,145,6941,229,898 total
  • Sale

    Common Stock

    2017-12-08$25.85/sh523,805$13,540,3591,390,723 total
Transactions
  • Sale

    Common Stock

    2017-12-08$25.85/sh523,805$13,540,3591,390,723 total
  • Sale

    Common Stock

    2017-12-11$25.85/sh160,375$4,145,6941,229,898 total
Footnotes (3)
  • [F1]Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  • [F2]Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  • [F3]This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.

Issuer

Tabula Rasa HealthCare, Inc.

CIK 0001651561

Entity typeother

Related Parties

1
  • filerCIK 0001125761

Filing Metadata

Form type
4/A
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 3:03 PM ET
Size
13.8 KB